Pernix Therapeutics

  • About Us
  • Products
  • Business Development
  • Investor Relations
    • Stock Information
    • Analyst Coverage
    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Shareholder Contacts
    • Information Requests
    • Management
    • Board of Directors
  • Webcasts
  • Careers
  • News
  • Contact
  • Articles Of Incorporation (Filed March 10, 2010)
  • Amended And Restated Charter Of The Audit Committee Of The Board Of Directors (Filed March 10, 2010)
  • Compensation Committee Charter (Filed March 10, 2010)
  • Nominating Committee Charter (Filed March 10, 2010)
  • Insider Trading Policy (Filed March 10, 2010)
  • Bylaws (Filed March 10, 2010)
  • Code Of Business Conduct And Ethics (Filed March 10, 2010)

Reporting Concerns or Complaints: Please direct items of this nature to: investorrelations@pernixtx.com.

You can report your concerns or complaints anonymously or confidentially by contacting our AlertLine at 1-800-683-6217

(English & Spanish)